Bionote USA Launches New In-Clinic Hematology Analyzer

Vcheck H analyzer offers 6-Diff and reticulocyte analysis

BIG LAKE, MINN. (January 6, 2025) – The Vcheck H provides in-clinic evaluation of white blood cells, red blood cells, platelets, reticulocytes and hemoglobin, delivering 35 reported parameters in 90 seconds or less. The system supports high throughput, processing up to 60 samples per hour for CBC and differential testing and up to 40 samples per hour for CBC, differential and reticulocyte analysis.

The Vcheck H is powered by three advanced testing technologies, including fluorescence flow cytometry, sheath flow impedance and colorimetry, delivering accurate and reliable results through simple single-button operation. Veterinarians also have the flexibility to select either optical or impedance platelet measurement, allowing them to align testing with their preferred methodology and clinical workflow.

“In-clinic hematology testing is essential to delivering high-quality patient care,” said Kalani Inez, director at Bionote USA. “The Vcheck H provides rapid, reliable results that help support timely clinical decisions and improved patient outcomes.”

The Vcheck H represents the latest expansion of the Vcheck diagnostic platform, which includes the Vcheck F series of quantitative in-clinic biomarker analyzers and assays, as well as the Vcheck C1 in-clinic chemistry analyzer launched in October 2025. Together, the Vcheck platform reinforces Bionote’s commitment to delivering fast, accurate and cost-effective diagnostics at the point of care.

For more information on the Vcheck H, visit www.bionote.com/vcheck-h. To learn more about Bionote’s other in-clinic analyzers and tests, visit www.bionote.com/veterinary-products.

Download Press Release